kernal biologics is mRNA vaccine and therapeutics company
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Phone: +1 857-600-0762
Total raised: $25M
Founded date: 2016
Investors 13
Show more
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.07.2022 | Series A | $25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 08.07.2022 | All the good news dealmakers need this weekend | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Who’s tired of it? Doom and gloom. Doom and gloom. And—just for good measure—a little more doom a... |
| 07.07.2022 | Kernal Biologics Raises $25M Series A Financing | Kernal Biologics, Inc., a Cambridge, Mass.-based development-stage mRNA-technology company developing cancer therapeutics designed to improve patients’ survival rate and quality of life, closed a $25m Series A financing. The round was led b... |
| 17.10.2018 | MassChallenge Awards $1.7M in Cash Prizes to Top Startups in Boston and Rhode Island | October 17, 2018, BOSTON – MassChallenge, a global network of zero-equity startup accelerators, tonight awarded $1 million in cash prizes to 15 of the highest-impact startups from the 2018 Boston accelerator and $500,000 to two startups in ... |
| 23.05.2018 | Announcing the 2018 MassChallenge Boston Cohort | We’re thrilled to introduce this year’s MassChallenge Boston cohort, which was selected from more than 1,600 applications from around the world, including 11 countries and 16 U.S. states. Representing the top 8% of all applicants, these 128... |